Thu.Jul 11, 2024

article thumbnail

Alcohol is driving a half-dozen types of cancer in the U.S., study finds

STAT

Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives a clearer sense of just how many cancer cases and deaths may be driven by drinking.  Researchers from the American Cancer Society and International Agency for Research on Cancer estimate 40% of all cancer cases in the United States in people 30 and up were due to “potentially modifiable risk factors,” including cigarette smoking, physical inactivity, consumption of processed meat, vi

364
364
article thumbnail

As feds crack down on PBMs for drug costs, Big Pharma could lose some of the heat

PharmaVoice

Drugmakers pointed the finger at PBMs for being the culprit behind rising drug prices in the U.S. for years — now, an ongoing FTC investigation has their back.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: Doctors ‘overprescribing’ opioids isn’t the cause of the overdose epidemic — and it never was

STAT

A key part of the federal government’s narrative about the epidemic of addiction and overdose deaths in the U.S. has been that it is driven by doctors and other clinicians overprescribing opioid painkillers. That story line is false — and was never true. The Centers for Disease Control and Prevention has traditionally relied on death certificate data compiled by the National Center for Health Statistics for its data on overdose deaths, organized as Underlying Cause of Death data us

364
364
article thumbnail

Pfizer thinks it found its obesity pill

BioPharma Dive

Far behind companies like Novo and Eli Lilly, Pfizer hopes the version of the drug, danuglipron, that it’s chosen to advance can break into the ultra-lucrative market for weight-loss medicines.

124
124
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Preparing schools for the H5N1 bird flu they’re likely to face

STAT

As Covid-19 swept across the United States, schools were among the most highly affected public spaces. To prepare for a potential H5N1 avian influenza jump to humans, schools need to be preparing for the scenario now before a sustained transmission event occurs. The response to Covid-19, which first appeared in the U.S. in early 2020, has been scrutinized by numerous case studies, after-action reports , and Congressional fact-finding hearings.

364
364
article thumbnail

Bill that would cut down ‘patent thickets’ clears Senate

pharmaphorum

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the prices of medicines in the US.

More Trending

article thumbnail

AbbVie appoints new Chief Scientific Officer

European Pharmaceutical Review

Dr Roopal Thakkar has been appointed as Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie. He is the company ’s current Senior Vice President, Chief Medical Officer, Global Therapeutics. “As AbbVie’s Chief Scientific Officer, Dr Thakkar will continue to build momentum across discovery and all stages of development to fully realise the potential of our diverse pipeline.

105
105
article thumbnail

Elmo and his friends are helping little kids (and grown-ups) with their ‘big feelings’ amid a mental health crisis

STAT

WASHINGTON — When Elmo asked “How is everybody doing?” back in January, he was not expecting the onslaught of stress, despair, and anxiety that hit his replies. “I’m just looking for somebody to talk to and show me some love if you know what I mean,” famous singer T-Pain wrote back to the red Muppet.

362
362
article thumbnail

Meet Ketaki Patwardhan - from experiements with dad to excipients and manufacturing at Roquette

Outsourcing Pharma

Ketaki Patwardhan, a global technical developer at Roquette, has built a remarkable career in the pharmaceutical industry by leveraging her curiosity and passion for science.

105
105
article thumbnail

STAT+: Pfizer says it will advance once-daily GLP-1 pill after all

STAT

Pfizer said Thursday that it plans to advance a new, once-a-day formulation of its experimental obesity drug danuglipron, meant to be a pill version in the same class as popular injections like Wegovy and Zepbound. The medicine had at one point been a key focus for many investors, with Pfizer talking up the potential of the obesity market and saying it had two potential experimental obesity medicines in development.

Diabetes 312
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

How is the rise of GenAI changing the field of pharma medical writing?

pharmaphorum

The rise of GenAI is revolutionising the field of pharma medical writing in biopharma. Explore how this innovative technology is transforming the industry and its impact on medical writing practices.

113
113
article thumbnail

STAT+: Medicare proposes to cover some digital therapies in a breakthrough for health tech firms

STAT

In what could prove to be a lifeline for a new crop of health tech startups, Medicare regulators proposed new codes that support payment for digital mental health treatments, like apps that deliver cognitive behavioral therapy. The new codes  in the Centers for Medicare and Medicaid Services’ 2025 Medicare Physician Fee Schedule Proposed Rule released this week would allow clinicians to bill for supplying apps and other digital treatments as part of behavioral health treatment, as we

306
306
article thumbnail

US FDA declines to approve Novo Nordisk’s weekly insulin

Express Pharma

The US Food and Drug Administration has declined to approve Novo Nordisk’s weekly insulin in patients with diabetes, the Danish drugmaker said on Wednesday. The health regulator in its so-called “complete response letter” sought more information related to the manufacturing process and the type 1 diabetes indication to complete the review, Novo said.

Diabetes 103
article thumbnail

Listen: Biotech layoffs, founder-focused VC, & a big pharma exit

STAT

Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

FTC said to be planning legal action against PBMs

pharmaphorum

The FTC is said to be gearing up to file lawsuits against the top three pharmacy benefit managers in the wake of its damning report on the sector.

121
121
article thumbnail

STAT+: Roche’s TIGIT study was a bust. What’s the outlook for its next big bet?

STAT

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here to get it delivered to their inbox. A few years back, TIGIT was hailed as the next blockbuster target for cancer immunotherapy. Based on early data, drugmakers were hopeful that blocking two checkpoint proteins on immune cells — TIGIT and PD-1/PD-L1 — would be more effective at killing tumors than just blocking one, potentially offering greater benef

article thumbnail

FDA’s lab-developed test rule could be first test of agency’s power post-Chevron

BioPharma Dive

The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.

108
108
article thumbnail

STAT+: Pharmalittle: We’re reading about a Pfizer daily weight loss pill, a Novo Nordisk setback, and more

STAT

Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, despite expectations of still more heat. The skies are clear and sunny, the birds are chirping, and the official mascots are capturing creatures on the Pharmalot campus this morning. This calls for celebration with a cup of stimulation, and we are opening a new package of blueberry muffin for the occasion.

Diabetes 237
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New policy review reveals ten cancer challenges facing new UK government

Pharma Times

Macmillan Cancer Support estimates that cancer affects over three million people in the UK

132
132
article thumbnail

Can you get satiety with GLP-1s without the nausea?

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news this morning, so let’s get straight into it.

article thumbnail

Clinical trial trends and the rise of site networks

pharmaphorum

Tune in to Caroline Redecker and Jason Casarella as they discuss clinical trial trends and the rise of site networks in this insightful podcast episode brought to you by Advanced Clinical.

108
108
article thumbnail

The end of condoms? Will men embrace the hormone-free birth control pill?

Outsourcing Pharma

In an exclusive interview, Akash Bakshi, CEO of YourChoice Therapeutics, delves into the inspiration and journey behind developing a hormone-free birth control pill for men.

100
100
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Zydus gains final FDA nod for Sacubitril and Valsartan Tablets

Express Pharma

Zydus Lifesciences has received final approval from the United States Food and Drug Administration to market Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg (USRLD: Entresto tablets). Sacubitril and Valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalisation.

96
article thumbnail

FDA rejects Novo Nordisk’s weekly basal insulin

pharmaphorum

FDA rejects Novo Nordisk’s once-weekly basal insulin for people with diabetes, which would reduce the number of injections needed

Diabetes 110
article thumbnail

Indegene collaborates with Microsoft to promote use of GenAI in global life sciences companies

Express Pharma

Indegene announced a strategic collaboration with Microsoft to empower global life sciences companies to scale up the adoption of purpose-built, enterprise-grade Generative AI services, thereby driving faster innovation at scale. Indegene and Microsoft have aimed to develop resources in highly specialised and skilled medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions.

article thumbnail

AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson's disease

World Pharma News

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track Designation for AB-1005, which is being developed for moderate Parkinson's disease. AB-1005 has also been awarded the Innovation Passport, the United Kingdom Medicines and Healthcare products Regulatory Agency (UK MHRA) innovative medicine designa

97
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CDMO Value Proposition: Why It Matters

Drug Patent Watch

The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry.

97
article thumbnail

The evolution of nutra CMOs into CDMOs

Express Pharma

Season 2 of the Express Pharma – Nutrify Today Boardroom series presents key dialogues from the Nutrify C Suite Sumflex 2024, held over June 6-7, 2024. In this video, industry leaders discuss the importance of adding D (development) capabilities for nutraceutical contract manufacturing organisations (CMOs). [+] Neetu Sharma, Advisor, BD Nutraceuticals (Moderator) [+] Suresh Garg, Managing Director, Zeon Life Sciences [+] Subba Rao MD, Managing Director, Crius Life Sciences [+] Rajiv Sanghvi, CEO

89
article thumbnail

SK Life Science Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team

pharmaphorum

SK Life Science Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team Mike.

118
118
article thumbnail

Researchers awarded £1.5m for national dementia inequalities network

Pharma Times

The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care

114
114
article thumbnail

SIIC IIT Kanpur, Boehringer Ingelheim collaborate to support dementia care innovation

Express Pharma

The Startup Incubation and Innovation Centre (SIIC) at the Indian Institute of Technology Kanpur (IITK) has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India, to advance solutions in the field of dementia care. The Boehringer Ingelheim India team, comprising Gagandeep Singh Bedi, MD and, Prabhat Sinha, Director of Government and Public Affairs, Corporate Affairs, visited SIIC, IIT Kanpur, to strengthen their partnership in fostering healthcare innovations.

84